Alex Kesin's Pharmacopoeia
Alex KesinRuminations about biotech and drug development - one overly earnest blog post at a time.
| Platform |  | Pricing | Freemium | Publishes | Weekly |
|---|---|---|---|---|---|
| Issues | 37 | Subscribers | Read | alexkesin.com |
Curious about how many subscribers Alex Kesin's Pharmacopoeia has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over three million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Latest Issues
Recent posts by this newsletter. Browse the email archive.
Anti-Amyloids and Antichrist
Some thoughts on Peter Thiel's view of the beta-amyloid hypothesis as a lens for understanding the messy, slow cost of figuring out how to make drugs for complex diseases.
A Better Proxy Than the Rat and Dog
Disclosure: This profile was commissioned by Axiom Bio. The company provided access to its offices, team, and partner meetings and reviewed drafts for factual accuracy.
Would Walter White Still Cook Meth in 2025?
You know what’s a fun way to spend a morning? Calculating whether a fictional chemistry teacher’s cancer would be treatable with modern targeted therapy and whether his employer health plan would cover it. I have done this. Let me tell you ...
Fun with FGF21
In September 2021, Bristol Myers Squibb discontinued development of pegbelfermin, a PEGylated version of a hormone called FGF21, after spending years and probably hundreds of millions of dollars testing it in patients with liver disease. Th...
Similar Newsletters
Other publications recommended by the authors of this newsletter.
Authors
The writers behind this newsletter.
I write about drugs (the legal kind).
Frequently Asked Questions
How can I access the email archive for Alex Kesin's Pharmacopoeia?
You can find recent issues that have been published by Alex Kesin's Pharmacopoeia on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Alex Kesin's Pharmacopoeia have?
To see how many people subscribe to Alex Kesin's Pharmacopoeia, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Alex Kesin's Pharmacopoeia?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Alex Kesin's Pharmacopoeia as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Alex Kesin's Pharmacopoeia?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Alex Kesin's Pharmacopoeia using the contact information provided and ask for a copy of their media kit.
How can I find newsletters similar to Alex Kesin's Pharmacopoeia?
Scroll up to where it says Similar Newsletters to see other publications like Alex Kesin's Pharmacopoeia. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Alex Kesin's Pharmacopoeia?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.